All In Biotech

Free tool

FAERS Monitor: Azulfidine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020465 or its brand name (Azulfidine, Sulfasalazine). Reports on generic versions are filed under their own applications.

Reports

77,206

Serious

64,651

84% of reports

Hospitalization

21,115

Death reported

7,369

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective29,465
  • rheumatoid arthritis19,619
  • pain16,065
  • drug intolerance13,852
  • arthralgia13,559
  • fatigue13,435
  • joint swelling12,834
  • off label use11,241
  • rash11,080
  • abdominal discomfort10,165
  • contraindicated product administered9,780
  • condition aggravated9,676
  • alopecia9,550
  • synovitis9,345
  • arthropathy9,279

Reports by year received

View as table
YearReports
2004617
2005576
2006640
2007694
2008721
2009788
2010865
20111,144
20121,439
20131,320
20141,450
20152,286
20163,208
20175,103
20186,182
20197,297
202011,184
20217,160
20227,093
20235,095
20245,714
20254,546
20262,083

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,976,953 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
synovitisSignal9,345291.7283.51,306,518
contraindicated product administeredSignal9,780129.4126.5845,388
rheumatoid arthritisSignal19,61956.755.9892,822
arthropathySignal9,27954.453.2406,112
drug intoleranceSignal13,85245.444.7517,992
joint swellingSignal12,83432.331.7349,761
abdominal discomfortSignal10,16517.517.2149,814
alopeciaSignal9,55013.913.6109,547
arthralgiaSignal13,5599.19.097,127
condition aggravatedSignal9,6768.98.866,856
painSignal16,0657.37.287,442
rashSignal11,0807.17.057,559
drug ineffectiveSignal29,4656.26.2134,237
fatigueSignal13,4354.84.740,797
off label useSignal11,2413.53.520,990

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.